STATE STREET CORP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$7,296,000
-13.5%
138,111
+0.4%
0.00%
-100.0%
Q2 2020$8,431,000
+10.2%
137,586
+1.7%
0.00%0.0%
Q1 2020$7,653,000
-2.7%
135,277
-2.1%
0.00%0.0%
Q4 2019$7,869,000
+12.4%
138,202
+5.6%
0.00%0.0%
Q3 2019$7,004,000
-6.1%
130,875
+4.7%
0.00%0.0%
Q2 2019$7,461,000
+1.6%
124,954
+6.0%
0.00%0.0%
Q1 2019$7,346,000
+11.6%
117,853
+8.5%
0.00%0.0%
Q4 2018$6,585,000
+7.8%
108,664
+4.1%
0.00%
Q3 2018$6,106,000
+32.7%
104,385
+1.8%
0.00%
Q2 2018$4,601,000
+4.4%
102,589
+3.2%
0.00%
Q1 2018$4,409,000
+9.0%
99,367
+6.4%
0.00%
Q4 2017$4,046,000
-8.6%
93,381
-1.9%
0.00%
Q3 2017$4,427,000
-10.9%
95,160
-5.2%
0.00%
Q2 2017$4,970,000
+1.8%
100,361
+12.7%
0.00%
Q1 2017$4,880,000
+6.7%
89,090
+8.5%
0.00%
Q4 2016$4,574,000
+31.7%
82,092
+7.9%
0.00%
Q3 2016$3,474,000
+20.1%
76,111
+5.1%
0.00%
Q2 2016$2,893,000
+15.4%
72,391
+0.5%
0.00%
Q1 2016$2,507,000
-14.3%
72,003
+5.7%
0.00%
Q4 2015$2,925,000
+85.6%
68,093
+69.2%
0.00%
Q1 2015$1,576,000
+21.0%
40,248
+19.5%
0.00%
Q4 2014$1,302,000
+17.3%
33,684
+7.3%
0.00%
Q3 2014$1,110,000
+1.3%
31,401
-57.3%
0.00%
Q4 2013$1,096,00073,4880.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders